09:00 - 09:40 | Experimental clinical neuropsychopharmacology of antidepressants Catherine Harmer, United Kingdom |
09:40 - 10:20 | Modern trends in clinical trial methodology Michael Davidson, Israel |
10:20 - 10:50 | Break |
10:50 - 12:30 | Presentations by 5 young scientists |
10:50 - 11:10 | Genetic variability at IMPA-2, INNP-1 and glycogen synthase kinase (GSK)-3ß increases the risk of suicidal behaviour in bipolar patients (P.3.010) junior speaker: Esther Jimenez, Spain |
11:10 - 11:30 | Neurocognitive impairment in euthymic bipolar disorder: a functional magnetic resonance imaging study with a working memory task (P.3.013) junior speaker: Laura Cremaschi, Italy |
11:30 - 11:50 | Acute mediofrontal and insular brain hypoperfusion after heroin administration in addicts: a within subject arterial spin labeling study (P.3.032) junior speaker: Niklaus Denier, Switzerland |
11:50 - 12:10 | A common variant in human ErbB4 regulates GABA cerebrospinal fluid concentrations (P.3.007) junior speaker: Christiaan Vinkers, Netherlands |
12:10 - 12:30 | Metabolic risk after six months of treatment with second-generation antipsychotics in antipsychotic-naïve children and adolescents (P.3.023) junior speaker: Covadonga M. Díaz-Caneja, Spain |
12:30 - 13:00 | General discussion |
| Lunch and free afternoon |